What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.01%
Annual Rate
CNY 0.01Paid annual
Payout Ratio
190.0%High
Last Ex-Dividend
Jul 10, 2026
The reported statements, read against the company's own industry.
What stands out
Valued far above the size of its business
Financials view
Market Capitalization
7.10BCNY
1.06B · vs all stocks (USD)
Updated Oct 21, 2026
Revenue (TTM)
392.16MCNY
58.78M · vs all stocks (USD)
Updated Oct 21, 2026
Profit Margin
-15.59%
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Beta
0.8680x
vs all stocks
Updated Oct 21, 2026
52-Week Change
73.36%
vs all stocks
Updated Oct 21, 2026
Market Capitalization
7.10BCNY
1.06B · vs all stocks (USD)
Updated Oct 21, 2026
Enterprise Value
6.29BCNY
942.77M · vs all stocks (USD)
Updated Oct 21, 2026
Price to Sales (TTM)
17.23x
vs Scientific & Technical Instruments peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 18.11×.Updated Oct 21, 2026
Price to Book (MRQ)
3.45x
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Enterprise to Revenue
16.04x
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Enterprise to EBITDA
-123.10x
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Gross Margin
17.07%
vs Scientific & Technical Instruments peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 21.02%.Updated Oct 21, 2026
Profit Margin
-15.59%
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Operating Margin
-38.92%
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Return on Assets (TTM)
-2.33%
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Return on Equity (TTM)
-3.28%
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Revenue (TTM)
392.16MCNY
58.78M · vs all stocks (USD)
Updated Oct 21, 2026
Revenue per Share (TTM)
2.11CNYUpdated Oct 21, 2026
Quarterly Revenue Growth
7.80%
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Gross Profit (TTM)
82.44MCNY
12.36M · vs all stocks (USD)
Updated Oct 21, 2026
EBITDA (TTM)
-51.09MCNY
-7.66M · vs all stocks (USD)
Updated Oct 21, 2026
Net Income (TTM)
-61.14MCNY
-9.16M · vs all stocks (USD)
Updated Oct 21, 2026
Quarterly Earnings Growth (YoY)
-10.28%
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Operating Cash Flow (TTM)
-2.03MCNY
-304.56K · vs all stocks (USD)
Updated Oct 21, 2026
Levered Free Cash Flow (TTM)
-37.42MCNY
-5.61M · vs all stocks (USD)
Updated Oct 21, 2026
Trailing Annual Dividend Rate
0.0050CNYUpdated Oct 21, 2026
Trailing Annual Dividend Yield
0.01%
vs all stocks
Updated Oct 21, 2026
Payout Ratio
190.00%
vs Scientific & Technical Instruments peers
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives -1.52%.Updated Oct 21, 2026
Minority Interest (Equity)
23.60MCNYFY2025 · Dec 31, 2025
Revenue
398.97MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
299.85MCNYFY2025 · Dec 31, 2025
Gross Profit
99.12MCNYFY2025 · Dec 31, 2025
Operating Income
-43.94MCNY
-6.59M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-96.81MCNYFY2025 · Dec 31, 2025
Income Tax Expense
-7.41MCNYFY2025 · Dec 31, 2025
Net Income
-89.39MCNYFY2025 · Dec 31, 2025
EBIT
-93.12MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
-11.20MCNYFY2025 · Dec 31, 2025
Research & Development
46.38MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
37.42MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
4.95MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
12.14MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
3.68MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.4800CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.4800CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
184.93MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
184.93MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-89.39MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
628.10KCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-24.58MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-28.25MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
169.91MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-89.39MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
4.59MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
121.28MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-61.05MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-3.66MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-808.00MCNYFY2025 · Dec 31, 2025
Sale of Investments
782.68MCNYFY2025 · Dec 31, 2025
Other Investing Activity
-11.87MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-40.85MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
45.00MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-103.77MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-6.51MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-44.64KCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-65.33MCNYFY2025 · Dec 31, 2025
Shares Outstanding
184.62MSharesUpdated Oct 21, 2026
Float Shares
122.64MSharesUpdated Oct 21, 2026
% Held by Insiders
32.86%
vs all stocks
Updated Oct 21, 2026
% Held by Institutions
5.27%
vs all stocks
Updated Oct 21, 2026
Total Cash (MRQ)
549.74MCNY
82.40M · vs all stocks (USD)
Updated Oct 21, 2026
Total Cash per Share (MRQ)
2.98CNYUpdated Oct 21, 2026
Total Debt (MRQ)
64.18MCNY
9.62M · vs all stocks (USD)
Updated Oct 21, 2026
Total Debt to Equity (MRQ)
0.0324x
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Current Ratio (MRQ)
5.19x
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Book Value per Share (MRQ)
10.62CNYUpdated Oct 21, 2026
Total Assets
2.42BCNY
362.88M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.47BCNYFY2025 · Dec 31, 2025
Total Liabilities
427.85MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
946.27MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
89.90MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
337.94MCNYFY2025 · Dec 31, 2025
Cash
169.91MCNYFY2025 · Dec 31, 2025
Cash Equivalents
35.61MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
205.52MCNYFY2025 · Dec 31, 2025
Accounts Receivable
399.42MCNYFY2025 · Dec 31, 2025
Inventory
241.19MCNYFY2025 · Dec 31, 2025
Accounts Payable
227.43MCNYFY2025 · Dec 31, 2025
Short-term Debt
19.91MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
5.28MCNYFY2025 · Dec 31, 2025
Long-term Debt
49.15MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
13.27MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
184.62MCNYFY2025 · Dec 31, 2025
Retained Earnings
557.50MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.99BCNY
298.75M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
14.00CNYUpdated Oct 21, 2026
52-Week High
61.61CNYUpdated Oct 21, 2026
52-Week Change
73.36%
vs all stocks
Updated Oct 21, 2026
Beta
0.8680x
vs all stocks
Updated Oct 21, 2026
50-Day MA
47.42CNYUpdated Oct 21, 2026
200-Day MA
28.74CNYUpdated Oct 21, 2026
Avg 10-Day Volume
21.86MSharesUpdated Oct 21, 2026
Avg 30-Day Volume
23.21MSharesUpdated Oct 21, 2026
Diluted EPS (TTM)
-0.3300CNYUpdated Oct 21, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
Sharp Decline With Volume And Volatility Expansion
A steep fall on heavy volume, leaving the price far below its peak.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 17.1%, lower than 95% of its Scientific & Technical Instruments peers (median 43.1%)Significant